about
TGFBI promoter hypermethylation correlating with paclitaxel chemoresistance in ovarian cancer.Bisphosphorylated PEA-15 sensitizes ovarian cancer cells to paclitaxel by impairing the microtubule-destabilizing effect of SCLIP.Recent progress in tumor pH targeting nanotechnology.A novel hTERT promoter-driven E1A therapeutic for ovarian cancer.The rationale for mTOR inhibition in epithelial ovarian cancer.
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Novel agents in ovarian cancer.
@en
type
label
Novel agents in ovarian cancer.
@en
prefLabel
Novel agents in ovarian cancer.
@en
P2860
P1476
Novel agents in ovarian cancer
@en
P2093
Daniela Matei
P2860
P304
P356
10.1517/13543784.16.8.1227
P407
P577
2007-08-01T00:00:00Z